NASDAQ:GCAN Greater Cannabis (GCAN) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free GCAN Stock Alerts $0.0007 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.0006▼$0.000850-Day Range N/A52-Week Range$0.0003▼$0.0015Volume399,500 shsAverage Volume3.39 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media Get Greater Cannabis alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Greater Cannabis Stock (NASDAQ:GCAN)The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, and other neuropsychiatric disorders. The Greater Cannabis Company, Inc. was founded in 2014 and is based in Baltimore, Maryland.Read More GCAN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GCAN Stock News HeadlinesApril 28, 2024 | msn.comHow Cannabis Laws Impact Immigration: New Study Links State Legalization To Less DeportationsApril 26, 2024 | msn.comMass. cannabis sales topped $1 billion for third straight year in 2023April 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 26, 2024 | msn.comMass. cannabis sales topped $1B for third straight year in 2023April 21, 2024 | msn.comUnionized cannabis workers picket Phoenix dispensary on 4/20 after contract negotiations stallApril 19, 2024 | benzinga.comCannabis Holds Promise In Treating Autism: GCANRx (OTCPK: GCAN) Is Taking It To The Next Level With Its Novel Neuropsychiatric Cannabinoid TherapyApril 18, 2024 | msn.comBen & Jerry's Says Marijuana Legalization Without Justice Is Half-Baked, Pushes For Record Clearing In ArizonaApril 14, 2024 | msn.comCannabis plants contain a chemical that can actually relieve cannabis-induced anxietyApril 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 11, 2024 | msn.comChemical found in cannabis plants can actually reduce cannabis-induced anxietyApril 11, 2024 | msn.comThe unregulated toxin in some cannabis and hemp productsApril 11, 2024 | msn.comNew Study Reveals One Cannabis Terpene Significantly Reduces THC-Caused AnxietyApril 10, 2024 | msn.comResearchers show chemical found naturally in cannabis may reduce anxiety-inducing effects of THCMarch 30, 2024 | msn.comGOP Governor Youngkin Vetoes Virginia Cannabis Sales Bill 3 Years After Legalization, Sparking Democratic OutrageMarch 28, 2024 | msn.comVirginia Gov. Glenn Youngkin vetoes marijuana billsMarch 14, 2024 | msn.comGrowing teen THC use could further complicate cannabis policyFebruary 28, 2024 | msn.comMedWatch Digest: Cannabis use could lead to heart problems — and moreFebruary 27, 2024 | globenewswire.comGCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid TherapyFebruary 16, 2024 | msn.comFact check: How dangerous is cannabis? Four myths exposedFebruary 14, 2024 | msn.comCannabis company taking over local grow facilityFebruary 5, 2024 | chron.comAmid growing legalization, cannabis in culture and politics is the focus of this anthropology courseFebruary 2, 2024 | nypost.comMarijuana use linked to increased asthma risk in youth: studyJanuary 28, 2024 | msn.comDid legal marijuana help or harm Californians? Here’s what the data saysJanuary 25, 2024 | msn.comStudy reveals link between cannabis use and current asthma prevalence in US adolescents and adultsJanuary 11, 2024 | msn.comHundreds of pounds of marijuana seized during search at California gardening storeJanuary 10, 2024 | msn.comWatsonville Planning Commission OKs change of ownership for two cannabis dispensariesJanuary 8, 2024 | msn.comHigh Yielding Cannabis StrainsSee More Headlines Receive GCAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Greater Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolNASDAQ:GCAN CUSIPN/A CIK1695473 Webwww.gcanrx.com Phone(443) 738-4051FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Aitan Zacharin (Age 41)Chairman, President, CEO, Acting CFO & Treasurer Comp: $120kMotti StengeChief Operating OfficerDr. Adi Aran M.D.Chief Scientific AdvisorKey CompetitorsAlvotechNASDAQ:ALVOWBiofronteraNASDAQ:BFRIWClever LeavesNASDAQ:CLVRWCyclo TherapeuticsNASDAQ:CYTHWProcaps GroupNASDAQ:PROCWView All Competitors GCAN Stock Analysis - Frequently Asked Questions How have GCAN shares performed in 2024? Greater Cannabis' stock was trading at $0.0009 at the beginning of the year. Since then, GCAN stock has decreased by 22.2% and is now trading at $0.0007. View the best growth stocks for 2024 here. What other stocks do shareholders of Greater Cannabis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Greater Cannabis investors own include Cannabix Technologies (BLOZF), Flowr (FLWPF), Trulieve Cannabis (TCNNF), Acreage (ACRGF), BioLineRx (BLRX), Camtek (CAMT), CNBX Pharmaceuticals (CNBX) and Cronos Group (CRON). How do I buy shares of Greater Cannabis? Shares of GCAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GCAN) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Greater Cannabis Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
